Cargando…
Caring for Patients with Advanced Stage Cancer at the Time of COVID‐19
This letter to the editor alerts oncologists to the importance of accurately defining benefit‐risk ratio during the COVID‐19 pandemic for patients with advanced‐stage cancer treated with chemotherapy after failure of first‐line and second‐line therapy.
Autores principales: | Brunello, Antonella, Zagonel, Vittorina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264766/ https://www.ncbi.nlm.nih.gov/pubmed/32307803 http://dx.doi.org/10.1634/theoncologist.2020-0230 |
Ejemplares similares
-
Older cancer patients and COVID‐19 outbreak: Practical considerations and recommendations
por: Brunello, Antonella, et al.
Publicado: (2020) -
Urine 2-Hydroxyglutarate in Glioma
por: Lombardi, Giuseppe, et al.
Publicado: (2016) -
Safety of COVID-19 Vaccine in Patients with Cancer in a High-Volume Comprehensive Cancer Center
por: Brunello, Antonella, et al.
Publicado: (2022) -
Validation of the Comprehensive Geriatric Assessment as a Predictor of Mortality in Elderly Glioblastoma Patients
por: Lombardi, Giuseppe, et al.
Publicado: (2019) -
Tumor biopsy and patient enrollment in clinical trials for advanced hepatocellular carcinoma
por: Rimassa, Lorenza, et al.
Publicado: (2017)